Market evolution: Medical instruments (CN 901890) — 2015–2025

Introduction

This report analyzes the trade dynamics of EU trade in instruments and appliances used in medical, surgical, or veterinary sciences, not elsewhere specified (CN 901890), for the period 2015–2025. The analysis focuses on identifying major trends in trade volumes, values, market structure, and external shocks to provide a comprehensive overview of the sector's evolution. The data reveals a period of robust growth for EU exporters, shifting trade partnerships, and a demonstrated capacity to adapt to significant global disruptions.

Overview of EU trade for CN 901890

1. Robust Growth and a Widening Trade Surplus

The EU's external trade in medical instruments (CN 901890) experienced significant expansion over the decade, characterized by strong export performance that outpaced import growth, leading to a substantially improved trade balance.

EU exports grew nearly twice as fast in value as in volume

Between 2015 and 2025, the value of EU exports to non-EU countries surged by 85.5%, from €8.46 billion to €15.68 billion. Over the same period, export volumes (net mass) increased by 25.4%, rising from 98,469 tonnes to 123,520 tonnes. This divergence indicates that the growth in export value was primarily driven by a significant rise in unit prices (up 47.9%), suggesting a shift in the EU's export basket towards higher-value products or successful price increases in existing segments.

Import growth was strong but trailed exports

EU imports from the rest of the world also grew considerably, increasing in value by 68.3% from €6.69 billion to €11.26 billion. Import volumes grew by 39.8% to 150,509 tonnes. While substantial, these growth rates were lower than those for exports, reflecting the EU's strengthening competitive position in this sector.

The EU's trade surplus more than doubled

The sustained outperformance of exports over imports resulted in a dramatic improvement in the EU's trade balance for medical instruments. The surplus grew from €1.76 billion in 2015 to €4.42 billion in 2025, an increase of 150.8%. This trend underscores the EU's role as a net exporter and a leading global supplier of these specialized goods.

Detailed trade overview and data

2. Shifting Trade Partnerships and Evolving Specialisation

The landscape of the EU's major trading partners for medical instruments evolved over the decade, marked by the rising importance of some emerging economies and shifts in the internal specialisation of EU member states.

The United States solidified its position as the EU's top export market

The United States remained the EU's largest single-country export destination, with exports to the US growing by 142.6% from €2.25 billion to €5.46 billion. This rapid growth highlights the strong demand for EU medical technology in the US market. Other significant growth was recorded for exports to Switzerland (+72.3%) and the Republic of Korea (+87.3%).

Import sources became slightly more diversified

The concentration of EU imports, as measured by the Herfindahl-Hirschman Index (HHI) for value, decreased by 23.0% from 2,188 to 1,685. While the United States remained the largest source of imports (+40.1% to €4.01 billion), imports from China (+159.9% to €1.15 billion) and Vietnam (+209.2% to €0.23 billion) grew at a much faster pace, contributing to the diversification of supply sources.

Internal EU specialisation intensified in specific member states

Analysis of revealed comparative advantage (RCA) for 2025 shows that EU export specialisation is concentrated in a few member states. The Netherlands (RCA 2.30), Ireland (RCA 1.66), and Finland (RCA 1.91) exhibit the highest levels of specialisation, meaning their exports of medical instruments are significantly more concentrated in this product category than the EU average. Germany remains the largest exporter by absolute value (€5.46 billion), followed by the Netherlands (€3.50 billion).

Data on top partners and internal EU specialisation

3. Disruptions, Shocks, and Adaptive Capacity

The period was not without volatility, as the sector faced significant supply chain shocks, most notably during the COVID-19 pandemic. However, the data suggests the EU's production and trade network demonstrated resilience and adaptability.

The COVID-19 pandemic triggered distinct trade and price shocks

The year 2020 stands out as a period of disruption. A major price shock was detected for imports from China, where the unit price spiked abnormally by 37.4%. This coincided with global surges in demand for medical equipment. Despite this, EU production volumes and values for medical instruments surged dramatically between 2015 and 2025, indicating a significant expansion of domestic manufacturing capacity. Production value increased by an extraordinary 649.2%, from €1.89 billion to €14.18 billion.

Supply volatility varies significantly by partner

The coefficient of variation (CV) for import values reveals that some supply relationships are more stable than others. Imports from Japan (CV 0.07) and the United States (CV 0.08) were the most stable over the period. In contrast, imports from Vietnam (CV 0.37) and the Dominican Republic (CV 0.34) showed much higher volatility, indicating potentially less predictable supply chains from these origins.

The endoscope segment demonstrated particular dynamism

Within the product breakdown, the endoscope sub-segment (90189020) showed remarkable growth in both imports and exports. Import values for endoscopes grew by 79.1% to €950 million, while export values exploded by 138.3% to €1.39 billion. This points to strong innovation, demand, and competitive positioning within this high-value niche.

Data on volatility and detected supply shocks

Conclusion

Over the 2015–2025 decade, the EU medical instruments sector (CN 901890) demonstrated robust health and growing competitiveness. The bloc successfully leveraged its position as a major exporter, achieving a widening trade surplus driven by both volume growth and significant price appreciation. The market structure evolved, with the US remaining a critical partner while import sources diversified slightly and internal EU specialisation concentrated in key member states. The sector faced substantial exogenous shocks, most notably the COVID-19 pandemic, but responded with a massive expansion in domestic production capacity. Overall, the data paints a picture of a dynamic, growing, and resilient industry that has strengthened its global trade position over the reviewed period.

Full data overview for CN 901890